Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress
FLT180a generated protective FIX levels with no bleeding or need for FIX replacement The treatment was well tolerated with a...